Ebola risk in Denmark ‘very, very small’: SSI

As Ebola-infected patients enter Western countries for treatment, Danish health officials say the virus could never spread here as it has in Africa.

Ebola risk in Denmark 'very, very small': SSI
Doctors wear protective gear in the southern Guinean town of Gueckedou. Photo: SEYLLOU/Scanpix
With over 700 people already killed by the worst recorded Ebola outbreak in history, Statens Serum Institut (SSI) says that the there is minimal risk that the spread of the virus will reach Denmark. 
If an Ebola-infected individual entered Denmark, SSI said the threat of contagion would be contained. 
“We view it as a very, very small probability,” SSI’s Anders Fomsgaard told Politiken. 
The Ebola virus has quickly spread through the African countries of Liberia, Sierra Leone and Guinea, but SSI says countries like Denmark are much better equipped to stop the spread of disease. 
“The sickness would never spread in the same way in a country like Denmark. Here, a person would seek out a doctor, be diagnosed and quickly get isolated if necessary and the health workers would track down people who may have been infected,” Fomsgaard said. 
The Ebola outbreak has begun to make its way to the West. Two American aid workers infected in Liberia were recently returned to the US for treatment and a hospital in Hamburg, Germany has recently agreed to accept Ebola patients for treatment
Fomsgaard said that any Danes who returned from West Africa and went to a Danish clinic or hospital for treatment would immediately be suspected of possibly carrying the Ebola virus and would have blood samples sent to SSI for testing. 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.


Ebola tests sold to Denmark recalled

The US Food and Drug Administration said that Ebola kits sent to Denmark and other countries could result in "life-threatening" false positives.

Ebola tests sold to Denmark recalled
Photo: Colourbox
US regulators have issued an international recall for a 10-minute Ebola blood test made by a California-based company, saying it has not been proven to work and could put lives at risk.
"A recall has been issued for the LuSys Laboratories, Inc., Ebola Virus One-Step Test Kits because the FDA has not cleared or approved the kits for use or sale," said the Food and Drug Administration in a statement emailed to reporters on Thursday.
"The results obtained from these test kits have not demonstrated to be accurate and should not be used as in vitro diagnostic tests for Ebola infection."
The recall was initially issued in mid-March and applies to test kits exported to Denmark, Sierra Leone and Canada between October 2014 and January 2015.
The FDA did not say how many tests were sent out.
The recall is described as a Class I, "the most serious type of recall and involve(s) situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death," the FDA said.
"A false positive result may be life-threatening by potentially placing the patient in an isolation cohort with Ebola-infected patients."
Contacted by AFP, a company representative in San Diego said early trials have shown the test to be 86 percent accurate.
The problem with the FDA came down to a labeling error, he said. The equipment had not been properly labeled "for research purposes only."